Ring Therapeutics IPO

Ring Therapeutics is a multi-product platform company focused on discovering and developing Anellovector therapeutics to unlock the full potential of gene therapy. Ring is aiming to pioneer the first redosable and targetable gene therapy platform by harnessing the biology of the human commensal virome. The company seeks to expand the applications of gene therapy beyond gene replacement, with the goal of enabling a much wider array of modalities and mechanisms to treat previously inaccessible diseases.

Register for Details

For more details on financing and valuation for Ring Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

What is Ring Therapeutics's ticker symbol?

Ring Therapeutics does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

What is Ring Therapeutics's stock price?

The stock price for Ring Therapeutics will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Ring Therapeutics Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
3/9/2023 Series C $600.06MM $XXX.XX $XXX.XX
7/28/2021 Series B $591.37MM $XXX.XX $XXX.XX
1/3/2020 Series A and A-1 $80.36MM $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Learn more about Ring Therapeutics

Forge green plus iconForge green minus icon

What is Ring Therapeutics funding to date?

Ring Therapeutics has raised $229.04MM with the following series:
$80.36MM for Series A and A-1, $591.37MM for Series B, $600.06MM for Series C, $80.36MM for Series A and A-1, $591.37MM for Series B, $600.06MM for Series C.
Forge green plus iconForge green minus icon

When was Ring Therapeutics founded?

Ring Therapeutics was founded in 2017.
Forge green plus iconForge green minus icon

Can you invest in Ring Therapeutics?

Ring Therapeutics is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Forge green plus iconForge green minus icon

Can you sell Ring Therapeutics share pre-IPO?

If you own Ring Therapeutics pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Is Ring Therapeutics a publicly traded company?

Ring Therapeutics is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Other companies like Ring Therapeutics in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$400.53MM
Sector
Last Round Est. Valuation
$4.26B
Sector
 
 
Sector
Last Round Est. Valuation
$1.08B
Sector